# AppTech Payments Corp.: overview APCX · OTC · CIK 1070050 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/apcx.md) · [Financials](/companies/apcx/financials.md) · [Filings](/companies/apcx/filings.md) · [Insiders](/companies/apcx/insiders.md) Latest reported revenue: [$1.7m](/filings/0001683168-26-006441.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001683168-26-006441). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [43.0](/filings/0001683168-25-008326.md) | [52.0 d](/filings/0001683168-26-002518.md) | [217](/filings/0001683168-26-004002.md) | [291](/filings/0001683168-26-006441.md) | [227](/filings/0001683168-25-008326.md) | [660 d](/filings/0001683168-26-002518.md) | [1,457](/filings/0001683168-26-004002.md) | [1,657](/filings/0001683168-26-006441.md) | | Gross margin | % | [44.2%](/filings/0001683168-25-008326.md) | [94.2% d](/filings/0001683168-26-002518.md) | [41.0%](/filings/0001683168-26-004002.md) | [63.2%](/filings/0001683168-26-006441.md) | [55.9%](/filings/0001683168-25-008326.md) | [56.2% d](/filings/0001683168-26-002518.md) | [55.7%](/filings/0001683168-26-004002.md) | [53.4%](/filings/0001683168-26-006441.md) | | Operating margin | % | [(4302.3%)](/filings/0001683168-25-008326.md) | [(3413.5%) d](/filings/0001683168-26-002518.md) | [(1224.0%)](/filings/0001683168-26-004002.md) | [(646.4%)](/filings/0001683168-26-006441.md) | [(692.1%)](/filings/0001683168-25-008326.md) | [(222.9%) d](/filings/0001683168-26-002518.md) | [(195.5%)](/filings/0001683168-26-004002.md) | [(53.6%)](/filings/0001683168-26-006441.md) | | Net margin | % | [(4709.3%)](/filings/0001683168-25-008326.md) | [(1825.0%) d](/filings/0001683168-26-002518.md) | [(1217.1%)](/filings/0001683168-26-006441.md) | [(639.2%)](/filings/0001683168-26-006441.md) | [(762.6%)](/filings/0001683168-25-008326.md) | [(255.8%) d](/filings/0001683168-26-002518.md) | [(227.0%)](/filings/0001683168-26-006441.md) | [(61.1%)](/filings/0001683168-26-006441.md) | | Diluted EPS | $ per share | [(0.08)](/filings/0001683168-25-008326.md) | not reported | [(0.08)](/filings/0001683168-26-004002.md) | [(0.06)](/filings/0001683168-26-006441.md) | [(0.05)](/filings/0001683168-25-008326.md) | not reported | [(0.08)](/filings/0001683168-26-004002.md) | [(0.02)](/filings/0001683168-26-006441.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [0.4](/filings/0001903596-23-000201.md) | [450](/filings/0001683168-24-002017.md) | [504](/filings/0001683168-25-002130.md) | [276](/filings/0001683168-26-002518.md) | [1,395](/filings/0001683168-26-002518.md) | | Gross margin | % | [57.6%](/filings/0001903596-23-000201.md) | [51.1%](/filings/0001683168-24-002017.md) | [62.9%](/filings/0001683168-25-002130.md) | [81.2%](/filings/0001683168-26-002518.md) | [55.3%](/filings/0001683168-26-002518.md) | | Operating margin | % | [21841.8%](/filings/0001903596-23-000201.md) | [(3607.6%)](/filings/0001683168-24-002017.md) | [(3806.5%)](/filings/0001683168-25-002130.md) | [(3459.1%)](/filings/0001683168-26-002518.md) | [(543.3%)](/filings/0001683168-26-002518.md) | | Net margin | % | [(22385746.9%)](/filings/0001575705-22-000237.md) | [(3618.0%)](/filings/0001683168-24-002017.md) | [(3673.0%)](/filings/0001683168-25-002130.md) | [(3236.6%)](/filings/0001683168-26-002518.md) | [(567.7%)](/filings/0001683168-26-002518.md) | | Diluted EPS | $ per share | not reported | [(1.00)](/filings/0001683168-24-002017.md) | [(1.01)](/filings/0001683168-25-002130.md) | [(0.35)](/filings/0001683168-26-002518.md) | [(0.23)](/filings/0001683168-26-002518.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/apcx/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Geneos Wealth Management Inc.](/funds/1764754.md) | 2026-06-30 | $680 | 2,000 | | Unchanged | ## Recent filings [All 291 filings](/companies/apcx/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 17:00 ET | [8-K](/filings/0001683168-26-008053.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-008053 | | 2026-10-06 | 21:08 ET | [8-K](/filings/0001683168-26-007665.md) | 5.02 Departure or appointment of officers or directors | 0001683168-26-007665 | | 2026-10-05 | 20:43 ET | [8-K](/filings/0001683168-26-007621.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-26-007621 | | 2026-08-14 | 19:14 ET | [8-K](/filings/0001683168-26-006467.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001683168-26-006467 | | 2026-08-14 | 17:18 ET | [10-Q](/filings/0001683168-26-006441.md) | Quarterly report, period 2026-06-30 | 0001683168-26-006441 | | 2026-07-21 | 20:10 ET | [8-K](/filings/0001683168-26-005678.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001683168-26-005678 | | 2026-07-10 | 15:11 ET | [8-K](/filings/0001683168-26-005441.md) | 5.02 Departure or appointment of officers or directors | 0001683168-26-005441 | | 2026-07-02 | 21:29 ET | [8-K](/filings/0001683168-26-005262.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001683168-26-005262 | | 2026-06-02 | 12:30 ET | [8-K](/filings/0001683168-26-004438.md) | 5.07 Shareholder vote results | 0001683168-26-004438 | | 2026-05-19 | 20:34 ET | [8-K/A](/filings/0001683168-26-004120.md) | 5.02 Departure or appointment of officers or directors | 0001683168-26-004120 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001683168-26-002518.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/290830c5-88b2-4ed4-ab34-0d06db6a5263) ## About the filer - CIK: 1070050 - Tickers: APCX, APCXW - Exchange: OTC - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.